BIIB122 225 mg

Drug identity checked against registry records

Also recorded as DNL151

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)NCT06602193DNLIPhase 2Active not recruiting2027-03Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.